Citadel Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607950. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$3,890,000
+67.9%
204,000
+71.9%
0.00%
+33.3%
Q1 2016$2,317,000
+19.4%
118,700
+136.0%
0.00%
+50.0%
Q4 2015$1,941,000
+23.4%
50,300
+2.7%
0.00%
+100.0%
Q3 2015$1,573,000
-29.6%
49,000
-33.2%
0.00%
-50.0%
Q2 2015$2,234,000
+502.2%
73,400
+163.1%
0.00%
Q1 2015$371,000
-20.4%
27,900
-13.4%
0.00%
Q4 2014$466,000
-48.6%
32,200
-25.1%
0.00%
-100.0%
Q3 2014$907,000
+0.1%
43,000
+41.4%
0.00%0.0%
Q2 2014$906,000
+21.6%
30,400
-1.9%
0.00%0.0%
Q1 2014$745,000
-34.6%
31,000
-44.5%
0.00%0.0%
Q4 2013$1,139,000
-73.2%
55,900
-37.8%
0.00%
-83.3%
Q3 2013$4,246,000
-19.5%
89,900
-35.1%
0.01%
-33.3%
Q2 2013$5,274,000138,6000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 597$4,449,0000.17%
GROUP ONE TRADING, L.P. 213,000$15,875,0000.02%
IMC-Chicago, LLC 57,600$4,293,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 717$00.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders